Product Recalls: A Practical Guide for Food Companies

What a recall actually involves, and where the decisions that matter get made.

A product recall compresses months of compliance activity into days. It runs through every part of the organization simultaneously and unfolds under CFIA oversight on a timeline the Agency sets. Most companies that go through one say the same thing afterward: they wish they had understood the process and their options better before it started.

This page is a practitioner's guide to Canadian food recalls: the framework, the process, and the points where the decisions that shape outcomes get made. It is written for the quality director, the general counsel, and the executive who needs to understand what is coming.

This page covers federal jurisdiction (CFIA and Health Canada). For an overview of CFIA's full enforcement toolkit, see CFIA Enforcement: A Practical Guide.

The Threshold: SFCR s. 82

Before a recall decision is reached, the law imposes an investigation obligation. Under SFCR s. 82(1), an operator who suspects on reasonable grounds that a food presents a risk of injury to human health must immediately investigate. If the investigation confirms a risk, s. 82(2) requires the operator to immediately notify the Minister and immediately take action to mitigate.

The s. 82 investigation is the first point where how the company handles the situation determines what comes next. A well-conducted investigation, properly documented, can distinguish between a genuine health risk (which triggers notification and typically leads to a recall) and a non-conformance that requires correction but does not meet the injury-to-health threshold. That distinction is often the difference between a recall and a market withdrawal.

The investigation records become part of the compliance file. If they are sloppy, incomplete, or conducted without awareness that they may later be reviewed by CFIA, examined by a tribunal, or produced in civil litigation, they create problems that outlast the investigation itself.

Market Withdrawal, Voluntary Recall, or Directed Recall

Not every product removal from the market is a recall. The three possible outcomes sit on a spectrum of regulatory severity, and where a particular situation lands on that spectrum is not always predetermined.

A market withdrawal (or stop sale) occurs when a company removes product without initiating a formal recall. CFIA may accept this for non-conformances that do not meet the recall threshold. A market withdrawal does not carry the same compliance record consequences as a recall.

A voluntary recall is initiated by the company. Canadian food recalls are generally voluntary: the company identifies a problem, notifies CFIA, and drives the process with CFIA in an oversight role. CFIA is often insistent on a voluntary recall without going to the lengths of directing a recall, typically to everyone’s benefit: a voluntary recall gives the company more control over timing, scope, and communications than a directed recall, and companies that cooperate early tend to fare better in the compliance record that follows.

A directed recall is ordered by the Minister for CFIA to carry out under s. 19(1) of the Canadian Food Inspection Agency Act when a company will not act voluntarily or when the risk is severe. Once issued, SFCA s. 5 prohibits the sale of the affected product. Contravening a directed recall order is a summary conviction offence under s. 19(2), carrying a fine up to $50,000, imprisonment up to six months, or both.

When the facts support it, presenting CFIA with evidence for a market withdrawal rather than a recall, or for a voluntary recall before CFIA has to direct one, changes the company's compliance trajectory. This requires evidence, not argument: the s. 82 investigation results, risk assessment data, exposure analysis. It is one of the most consequential interventions counsel can make.

How Recalls Are Classified

CFIA classifies recalls by the severity of the health risk. Classification is CFIA policy, not a statutory scheme, but it drives the operational tempo, public communication requirements, and CFIA monitoring intensity. These are the three classes of recalls:

Class I. A reasonable probability that use of, or exposure to, the product will cause serious adverse health consequences or death. Most undeclared allergen recalls are Class I (see Canadian Food Labelling Requirements) for the allergen declaration framework, even without reported illnesses, because CFIA treats the potential consequence as the operative risk. Requires immediate consumer and trade notification, a public advisory, and effectiveness checks.

Class II. Temporary adverse health consequences or a remote probability of serious consequences. Similar process to Class I on a less compressed timeline. Public advisories may or may not be issued.

Class III. Not likely to cause adverse health consequences. Typically labelling or compositional issues. No public advisory in most cases, but the recall remains on the CFIA database and on the compliance record.

Classification is not unilateral. CFIA proposes a recall classification, and the company can present evidence for a different classification. The evidence is factual: lab results, risk assessments, exposure data, consumption patterns. Getting a Class I down to a Class II changes the public communication obligation. Getting a Class III resolved as a market withdrawal keeps the event off the recall record entirely. This is practitioner work that requires understanding both CFIA's classification criteria and what evidence actually changes the assessment.

The Recall Process

Once the decision to recall is made, the process follows a predictable sequence (the timelines compress for Class I).

Scope

Defining what is being recalled is the first task and the one with the least room for error. Which products, lot codes, best-before dates, distribution channels? Are co-packed or private-label versions affected? The scope definition depends entirely on the company's traceability records. Companies with organized one-step-forward/one-step-back traceability under the SFCR will be able to narrow the recall to specific lots. Companies with weak records face a broader recall, potentially all production of the affected product, because they cannot demonstrate which lots are clear.

A recall scope that has to be expanded after the initial announcement generates a second notice and a second news cycle. That outcome is worse than getting the scope right the first time, even if the initial scope is broader than the company would prefer.

CFIA Engagement

For a voluntary recall, the company provides CFIA with a recall strategy specifying scope, distribution channels, and a notification plan. CFIA reviews and may request modifications. The recall does not begin formally until CFIA accepts the strategy.

The company's initial communications with CFIA set the tone for the entire file. The recall strategy document is a negotiation document as much as a compliance document. Companies that contact CFIA with a plan before CFIA contacts them about a problem are treated differently from companies that CFIA has to chase.

Notification

Trade notification is the company's responsibility: notify direct customers, instruct them to stop selling, quarantine product, and arrange return or disposal. For products that moved through multiple distribution tiers, the company typically needs to trace two steps down the chain. Consumer notification for Class I and II recalls is handled through the joint CFIA/Health Canada public advisory system.

Root Cause Analysis

CFIA will expect a root cause analysis explaining how the non-conformance occurred and a corrective action plan describing what the company will do to prevent recurrence. Both are submitted to CFIA and become part of the compliance record. They also become evidence in any subsequent AMP proceeding or CART review. See AMP Challenges: Responding to a CFIA Notice of Violation.

The root cause analysis is a strategic document, not a compliance formality. It shapes CFIA's assessment of whether the company understands its own failure and has a credible response. A superficial analysis will not satisfy the Agency. A credible, specific RCA can be the difference between CFIA treating the recall as an isolated incident and treating it as evidence of a systemic problem.

Legal Exposure

A recall can open multiple fronts simultaneously: CFIA enforcement (an AMP for the underlying violation, independent of the recall), product liability (civil claims from injured consumers, particularly in allergen and pathogen cases), customer claims (retailers and distributors seeking recovery for handling costs and destroyed inventory), insurance (confirming coverage before the event, not during it), and for public companies, disclosure obligations.

The recall also leaves a long-tail mark. It feeds CFIA's Establishment Risk Assessment (ERA) model, which determines inspection frequency. A company that has been through a recall can expect heightened scrutiny on subsequent inspections, particularly if the root cause analysis revealed weaknesses in the preventive control plan. The compliance record consequence often outweighs the immediate cost of the recall itself.

Where Counsel Fits

The conventional framing is that counsel is needed for the big recalls. That misses where counsel actually changes outcomes.

Counsel's greatest impact is often at points the company may not recognize as legal decisions: conducting the s. 82 investigation in a way that produces clean, defensible records; presenting evidence to CFIA for the correct classification or a market withdrawal resolution; defining the recall scope precisely enough to avoid expansion; drafting the company's first written response to CFIA, which sets the narrative for the entire file; and shaping the root cause analysis as a document that serves the company's long-term compliance position, not just the immediate obligation.

At the operational level, counsel coordinates across the multiple fronts a recall opens. The regulatory response, the insurance claim, the civil exposure, and the disclosure analysis run simultaneously, and the positions taken in each need to be consistent. What you say to CFIA becomes part of the record in a civil claim. What you tell your insurer needs to align with what you tell the Agency.

GSJ&Co. advises food companies on recalls across the full range, from market withdrawal negotiations to Class I allergen recalls with illness reports and downstream civil exposure. Contact us at info@gsjameson.com or +1 (647) 638-3994.

Product Recall Response Checklist

For general guidance only. Not a substitute for legal advice.

IMMEDIATE (First Hours):

☐ Conduct internal risk assessment under SFCR s. 82: does the company have reasonable grounds to suspect a risk of injury?

☐ If investigation confirms risk: notify the Minister immediately under s. 82(2)

☐ Convene the recall team: quality, operations, sales, communications, legal

☐ Pull production and distribution records for the affected lot(s)

☐ Implement document preservation hold on all related records

☐ Do not make admissions or preliminary statements without legal review

WITHIN 24 HOURS:

☐ Retain external legal counsel

☐ Assess CFIA's proposed classification; evaluate whether evidence supports a different classification or market withdrawal

☐ Define scope using traceability records

☐ Notify insurer and confirm recall coverage

☐ Assess supply agreement obligations to customers

WITHIN 72 HOURS:

☐ Submit recall strategy to CFIA

☐ Prepare and send trade notification

☐ Prepare consumer notification (required for Class I; assess for Class II)

☐ Quarantine affected product and instruct supply chain partners to do the same

ONGOING:

☐ Maintain a log of all communications with CFIA

☐ Coordinate with CFIA during effectiveness checks

☐ Prepare root cause analysis and corrective action plan

☐ Document all recall costs for insurance and customer claims

☐ Monitor compliance record and ERA score impact

Primary Authorities

Last updated: March 2026. This page is maintained by GSJ&Co. and updated when there are material changes to CFIA recall practice or the governing legislation.